Barros-Núñez P - Search Results

1

[Usefulness of molecular biology techniques in the diagnosis of fragile X syndrome].

Rosales-Reynoso MA, Barros-Núñez P. Rosales-Reynoso MA, et al. Gac Med Mex. 2003 Jul-Aug;139(4):413-4. Gac Med Mex. 2003. PMID: 14574764 Spanish. No abstract available.

2

Molecular characterization of the fragile-X syndrome in the Mexican population.

Díaz-Gallardo MY, Barros-Núñez P, Díaz CA, Hernández A, Gómez-Espinel I, Leal CA, Fragoso R, Figuera L, García-Cruz D, Ramírez-Dueñas ML. Díaz-Gallardo MY, et al. Arch Med Res. 1995;26 Spec No:S77-83. Arch Med Res. 1995. PMID: 8845662

3

Genetic diversity at the FMR1 locus in Mexican population.

Rosales-Reynoso MA, Mendoza-Carrera F, Troyo-Sanromán R, Medina C, Barros-Núñez P. Rosales-Reynoso MA, et al. Arch Med Res. 2005 Jul-Aug;36(4):412-7. doi: 10.1016/j.arcmed.2004.05.005. Arch Med Res. 2005. PMID: 15950084

4

[Methylation of DNA: a marker for the diagnosis and prognosis in cancer].

Mesa-Cornejo VM, Barros-Núñez P, Medina-Lozano C. Mesa-Cornejo VM, et al. Gac Med Mex. 2006 Jan-Feb;142(1):81-2. Gac Med Mex. 2006. PMID: 16548299 Spanish. No abstract available.

5

PCR approach for detection of Fragile X syndrome and Huntington disease based on modified DNA: limits and utility.

Rosales-Reynoso MA, Vilatela EA, Ojeda RM, Arce-Rivas A, Sandoval L, Troyo-Sanromán R, Barros-Núñez P. Rosales-Reynoso MA, et al. Genet Test. 2007 Summer;11(2):153-9. doi: 10.1089/gte.2006.0508. Genet Test. 2007. PMID: 17627386

6

Genetic variation of the FMR1 gene among four Mexican populations: Mestizo, Huichol, Purepecha, and Tarahumara.

Barros-Núñez P, Rosales-Reynoso MA, Sandoval L, Romero-Espinoza P, Troyo-Sanromán R, Ibarra B. Barros-Núñez P, et al. Am J Hum Biol. 2008 May-Jun;20(3):259-63. doi: 10.1002/ajhb.20705. Am J Hum Biol. 2008. PMID: 18172867

7

[Molecular diagnosis in Huntington's disease].

Rosales-Reynoso MA, Barros-Núñez P. Rosales-Reynoso MA, et al. Gac Med Mex. 2008 May-Jun;144(3):271-3. Gac Med Mex. 2008. PMID: 18714598 Spanish.

8

[Diseases caused by triplet expansion].

Rosales-Reynoso MA, Ochoa-Hernández AB, Barros-Núñez P. Rosales-Reynoso MA, et al. Rev Neurol. 2009 Jul 16-31;49(2):79-87. Rev Neurol. 2009. PMID: 19598137 Free article. Review. Spanish.

9

Gene expression profiling identifies WNT7A as a possible candidate gene for decreased cancer risk in fragile X syndrome patients.

Rosales-Reynoso MA, Ochoa-Hernández AB, Aguilar-Lemarroy A, Jave-Suárez LF, Troyo-Sanromán R, Barros-Núñez P. Rosales-Reynoso MA, et al. Arch Med Res. 2010 Feb;41(2):110-118.e2. doi: 10.1016/j.arcmed.2010.03.001. Arch Med Res. 2010. PMID: 20470940

10

FMR1 protein expression in blood smears for fragile X syndrome diagnosis in a Mexican population sample.

Romero-Espinoza P, Rosales-Reynoso MA, Willemsen R, Barros-Núñez P. Romero-Espinoza P, et al. Genet Test Mol Biomarkers. 2010 Aug;14(4):511-4. doi: 10.1089/gtmb.2009.0172. Genet Test Mol Biomarkers. 2010. PMID: 20642356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters